INTRODUCTION
• Hospital readmission is costly. Under the Affordable Care Act (hospital readmission reduction program -HRRP), hospitals face a financial penalty for readmissions within 30 days. • The LACE index 1 (Table 1) is one of the recommended assessment tools for identifying patients at risk of 30-day hospital readmission by many institutes and hospital associations. • Validation studies of the LACE index showed that its discriminative performance in identifying patients at high risk of readmission varies by populations. For example, the LACE Index had poor discriminative performance in the UK 2 , and moderate discriminative performance in Singapore. 3
OBJECTIVES
• To examine the LACE index's ability to identify patients with high risk of hospital readmissions in the US population. 
METHODS

Research Design: Retrospective study
Outcome: LACE index score and 30-day hospital readmission
Statistical analysis: Discrimination performance was assessed by area under the receiver operating characteristic (ROC). Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for 2 cut-off values (LACE index ≥ 7 and LACE index ≥ 10). All analyses were conducted in 2 populations; all patients and patients with HRRP-targeted medical conditions. STATA version 13.0 was used for all analyses.
HRRP-targeted medical conditions: acute myocardial infarction (AMI), heart failure (HF), pneumonia (PN), and chronic obstructive pulmonary disease (COPD).
RESULTS
• The 30-day hospital readmission rate was10.25% (701/6,836) for all patients. In the HRRP-targeted medical conditions group, the 30-day hospital readmission rate was 12.79% (109/852). • The LACE index had discriminative power of 0.5924 in all patients, and 0.5526 in patients with HRRP-targeted medical conditions. • Both cut-off score scores (7 and 10) yielded low sensitivity (≤ 70%).
CONCLUSIONS
• The LACE index performed poorly in predicting 30-day hospital readmission in both general population and HRRPtargeted medical conditions population. • Future risk assessment tool for 30-day hospital readmission may need to include clinical factors to increase the prediction accuracy.
LIMITATIONS
• Self-reported data may be subject to recall bias.
• Planned or unplanned hospital readmissions could not be determined. Emergency visits in the previous 6 months 
